A
Amylyx Pharmaceuticals (AMLX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Amylyx Pharmaceuticals (AMLX)
Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The Comp... Read more
- USD8.41
- USD8.41
- USD7.88
- USD8.47
- 52.40%
- 2.00M
- 1.74M
- 685M
- 1.76
- 289.40%
Stock News
1 hour ago
S&P 500 stumbles after hitting intraday high — the downside of a narrow rally
MarketWatch
1 hour ago
Amazon turns to rival SpaceX to launch next batch of Kuiper internet satellites
CNBC
2 hours ago
GM expands production of gas-powered SUV, trucks in Michigan
CNBC
3 hours ago
Trump's new trade deal promises billions to the U.S. — plus, reasons behind the mixed market
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
